Skip to content

Prime Medicine PRME Common Stock Shares Issued

Common Stock Shares Issued at other companies

Opus Genetics logo
Opus GeneticsIRD
71.4M+57.0%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
53.1M+90.1%
Precigen logo
PrecigenPGEN
355.9M+20.6%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
102.5M+25.6%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's common stock shares issued?
Prime Medicine (PRME) reported common stock shares issued of 180.6M in Q1 2026.
How has Prime Medicine's common stock shares issued changed year-over-year?
Prime Medicine's common stock shares issued increased by 37.7% year-over-year, from 131.2M to 180.6M.
What is the long-term trend for Prime Medicine's common stock shares issued?
Over 4 years (2021 to 2025), Prime Medicine's common stock shares issued has grown at a 53.6% compound annual growth rate (CAGR), from 32.4M to 180.5M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.